These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
391 related articles for article (PubMed ID: 11061876)
1. Surveillance of upper urinary tract transitional cell carcinoma: the role of ureteroscopy, retrograde pyelography, cytology and urinalysis. Chen GL; El-Gabry EA; Bagley DH J Urol; 2000 Dec; 164(6):1901-4. PubMed ID: 11061876 [TBL] [Abstract][Full Text] [Related]
2. Correlation of upper-tract cytology, retrograde pyelography, ureteroscopic appearance, and ureteroscopic biopsy with histologic examination of upper-tract transitional cell carcinoma. Williams SK; Denton KJ; Minervini A; Oxley J; Khastigir J; Timoney AG; Keeley FX J Endourol; 2008 Jan; 22(1):71-6. PubMed ID: 18315477 [TBL] [Abstract][Full Text] [Related]
3. Retrograde endoscopic laser therapy and ureteroscopic surveillance for transitional cell carcinoma of the upper urinary tract. Mugiya S; Ozono S; Nagata M; Otsuka A; Takayama T; Nagae H Int J Urol; 2006 Jan; 13(1):1-6. PubMed ID: 16448423 [TBL] [Abstract][Full Text] [Related]
4. Ureteroscopic management of upper tract transitional cell carcinoma in patients with normal contralateral kidneys. Chen GL; Bagley DH J Urol; 2000 Oct; 164(4):1173-6. PubMed ID: 10992360 [TBL] [Abstract][Full Text] [Related]
5. Ureteropyeloscopic diagnosis and treatment of upper urinary tract urothelial malignancies. Grasso M; Fraiman M; Levine M Urology; 1999 Aug; 54(2):240-6. PubMed ID: 10443718 [TBL] [Abstract][Full Text] [Related]
6. The Impact of Upper Tract Urothelial Carcinoma Diagnostic Modality on Intravesical Recurrence after Radical Nephroureterectomy: A Single Institution Series and Updated Meta-Analysis. Sharma V; Miest TS; Juvet TS; Toussi A; Packiam V; Chamie K; Matin SF; Boorjian SA; Thompson RH; Frank I; Tollefson MK; Potretzke AM J Urol; 2021 Sep; 206(3):558-567. PubMed ID: 33908802 [TBL] [Abstract][Full Text] [Related]
7. Ureteroscopic treatment and surveillance of upper urinary tract transitional cell carcinoma. Keeley FX; Bibbo M; Bagley DH J Urol; 1997 May; 157(5):1560-5. PubMed ID: 9112476 [TBL] [Abstract][Full Text] [Related]
8. Fluorodeoxyglucose positron emission tomography/computed tomography for diagnosis of upper urinary tract urothelial carcinoma. Asai S; Fukumoto T; Tanji N; Miura N; Miyagawa M; Nishimura K; Yanagihara Y; Shirato A; Miyauchi Y; Kikugawa T; Yokoyama M Int J Clin Oncol; 2015 Oct; 20(5):1042-7. PubMed ID: 25794920 [TBL] [Abstract][Full Text] [Related]
9. Cytologic analysis of ureteral washings is informative in patients with grade 2 upper tract TCC considering endoscopic treatment. Skolarikos A; Griffiths TR; Powell PH; Thomas DJ; Neal DE; Kelly JD Urology; 2003 Jun; 61(6):1146-50. PubMed ID: 12809884 [TBL] [Abstract][Full Text] [Related]
10. The value of upper tract cytology after transurethral resection of bladder tumor in patients with bladder transitional cell cancer. Sadek S; Soloway MS; Hook S; Civantos F J Urol; 1999 Jan; 161(1):77-9; discussion 79-80. PubMed ID: 10037373 [TBL] [Abstract][Full Text] [Related]
11. Preoperative hydronephrosis, ureteroscopic biopsy grade and urinary cytology can improve prediction of advanced upper tract urothelial carcinoma. Brien JC; Shariat SF; Herman MP; Ng CK; Scherr DS; Scoll B; Uzzo RG; Wille M; Eggener SE; Terrell JD; Lucas SM; Lotan Y; Boorjian SA; Raman JD J Urol; 2010 Jul; 184(1):69-73. PubMed ID: 20478585 [TBL] [Abstract][Full Text] [Related]
12. [Diagnostic procedures in upper urinary tract urothelial carcinoma]. Patschan O; Horstmann M; Thomas C; Schlemmer HP; Stenzl A Urologe A; 2008 Nov; 47(11):1487-96. PubMed ID: 19011832 [TBL] [Abstract][Full Text] [Related]
13. Impact of delay to nephroureterectomy for patients undergoing ureteroscopic biopsy and laser tumor ablation of upper tract transitional cell carcinoma. Boorjian S; Ng C; Munver R; Palese MA; Vaughan ED; Sosa RE; Del Pizzo JJ; Scherr DS Urology; 2005 Aug; 66(2):283-7. PubMed ID: 16098357 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of DD23 as a marker for detection of recurrent transitional cell carcinoma of the bladder in patients with a history of bladder cancer. Gilbert SM; Veltri RW; Sawczuk A; Shabsigh A; Knowles DR; Bright S; O'Dowd GJ; Olsson CA; Benson MC; Sawczuk IS Urology; 2003 Mar; 61(3):539-43. PubMed ID: 12639642 [TBL] [Abstract][Full Text] [Related]